Peter Libby

219.1k total citations · 80 hit papers
768 papers, 148.1k citations indexed

About

Peter Libby is a scholar working on Immunology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Libby has authored 768 papers receiving a total of 148.1k indexed citations (citations by other indexed papers that have themselves been cited), including 343 papers in Immunology, 264 papers in Surgery and 157 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Libby's work include Atherosclerosis and Cardiovascular Diseases (253 papers), Lipoproteins and Cardiovascular Health (129 papers) and Cell Adhesion Molecules Research (112 papers). Peter Libby is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (253 papers), Lipoproteins and Cardiovascular Health (129 papers) and Cell Adhesion Molecules Research (112 papers). Peter Libby collaborates with scholars based in United States, Germany and United Kingdom. Peter Libby's co-authors include Paul M. Ridker, Göran K. Hansson, Galina K. Sukhova, Uwe Schönbeck, Attilio Maseri, Masanori Aikawa, Ralph Weissleder, François Mach, Robert J. Glynn and Jean MacFadyen and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Peter Libby

750 papers receiving 144.3k citations

Hit Papers

Inflammation in atherosclerosis 1989 2026 2001 2013 2002 2002 2008 2009 2011 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inflammation in atherosclerosis
    2002 6.5k citations Peter Libby profile →
  2. Inflammation and Atherosclerosis
    2002 6.0k citations Peter Libby, Paul M. Ridker et al. Circulation profile →
  3. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
    2008 4.7k citations Paul M. Ridker, Eleanor Danielson et al. New England Journal of Medicine profile →
  4. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
    2009 2.9k citations Paul M. Ridker, Eleanor Danielson et al. profile →
  5. Progress and challenges in translating the biology of atherosclerosis
    2011 2.9k citations Peter Libby, Paul M. Ridker et al. profile →
  6. Inflammation in Atherosclerosis
    2012 2.7k citations Peter Libby Arteriosclerosis Thrombosis and Vascular Biology profile →
  7. Diabetes and Atherosclerosis
    2002 2.1k citations Joshua A. Beckman, Mark A. Creager et al. JAMA profile →
  8. Atherosclerosis
    2019 2.0k citations Peter Libby, Lâle Tokgözoğlu et al. profile →
  9. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
    2011 1.8k citations Peter Libby et al. profile →
  10. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
    2007 1.8k citations Matthias Nahrendorf, Filip K. Świrski et al. The Journal of Experimental Medicine profile →
  11. The immune response in atherosclerosis: a double-edged sword
    2006 1.7k citations Peter Libby et al. profile →
  12. Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
    2009 1.7k citations Filip K. Świrski, Matthias Nahrendorf et al. Science profile →
  13. The changing landscape of atherosclerosis
    2021 1.6k citations Peter Libby profile →
  14. Inflammation in Atherosclerosis
    2009 1.6k citations Peter Libby, Paul M. Ridker et al. profile →
  15. Molecular Bases of the Acute Coronary Syndromes
    1995 1.5k citations Peter Libby Circulation profile →
  16. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
    2006 1.5k citations Peter Libby et al. JAMA profile →
  17. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
    1995 1.4k citations Peter Libby et al. Journal of Clinical Investigation profile →
  18. Pathophysiology of Coronary Artery Disease
    2005 1.3k citations Peter Libby et al. Circulation profile →
  19. Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
    1998 1.3k citations Galina K. Sukhova, Peter Libby et al. profile →
  20. Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
    2001 1.2k citations Peter Libby Circulation profile →
  21. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
    2007 966 citations Filip K. Świrski, Peter Libby et al. Journal of Clinical Investigation profile →
  22. Inflammation and cardiovascular disease mechanisms
    2006 840 citations Peter Libby profile →
  23. Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
    2013 837 citations Peter Libby New England Journal of Medicine profile →
  24. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells
    1989 809 citations Peter Libby et al. profile →
  25. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
    2002 790 citations Peter Libby et al. profile →
  26. Local proliferation dominates lesional macrophage accumulation in atherosclerosis
    2013 779 citations Jose‐Luiz Figueiredo, Galina K. Sukhova et al. profile →
  27. Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
    2004 769 citations Peter Libby et al. JAMA profile →
  28. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
    2009 751 citations Paul M. Ridker, Eleanor Danielson et al. profile →
  29. Obesity, inflammation, and atherosclerosis
    2009 740 citations Peter Libby et al. Nature Reviews Cardiology profile →
  30. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
    1998 726 citations Galina K. Sukhova, Peter Libby et al. profile →
  31. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
    2007 707 citations Peter Libby et al. profile →
  32. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
    2000 667 citations Peter Libby et al. Journal of Clinical Investigation profile →
  33. Targeting inflammation in atherosclerosis — from experimental insights to the clinic
    2021 666 citations Peter Libby et al. profile →
  34. Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
    2011 644 citations Peter Libby et al. New England Journal of Medicine profile →
  35. COVID-19 is, in the end, an endothelial disease
    2020 618 citations Peter Libby, Thomas F. Lüscher European Heart Journal profile →
  36. Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
    2011 609 citations Paul M. Ridker, Tom Thurén et al. profile →
  37. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
    2009 604 citations Galina K. Sukhova, Peter Libby et al. profile →
  38. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
    2008 603 citations Christian Weber, Peter Libby et al. profile →
  39. The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
    2001 603 citations Peter Libby et al. profile →
  40. Inflammation and plaque vulnerability
    2015 599 citations Peter Libby, Ira Tabas et al. profile →
  41. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis
    1997 588 citations Galina K. Sukhova, Peter Libby et al. profile →
  42. Inflammation in Atherosclerosis: Transition From Theory to Practice
    2010 587 citations Peter Libby et al. profile →
  43. Macrophage Myeloperoxidase Regulation by Granulocyte Macrophage Colony-Stimulating Factor in Human Atherosclerosis and Implications in Acute Coronary Syndromes
    2001 585 citations Galina K. Sukhova, Renu Virmani et al. profile →
  44. Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB
    1995 580 citations Peter Libby et al. profile →
  45. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    1998 576 citations Peter Libby et al. profile →
  46. Chronic variable stress activates hematopoietic stem cells
    2014 575 citations Peter Libby, Filip K. Świrski et al. profile →
  47. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
    1994 574 citations Galina K. Sukhova, Peter Libby et al. profile →
  48. Cardiovascular remodelling in coronary artery disease and heart failure
    2014 571 citations Peter Libby et al. profile →
  49. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.
    1991 566 citations Peter Libby et al. profile →
  50. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
    2012 562 citations Paul M. Ridker, Jean MacFadyen et al. profile →
  51. Atherosclerosis and inflammation: overview and updates
    2018 554 citations Peter Libby et al. profile →
  52. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium.
    1993 552 citations Peter Libby et al. profile →
  53. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.
    1995 547 citations Peter Libby et al. profile →
  54. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
    2009 543 citations Robert J. Glynn, Eleanor Danielson et al. New England Journal of Medicine profile →
  55. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.
    1998 532 citations Galina K. Sukhova, Guo‐Ping Shi et al. Journal of Clinical Investigation profile →
  56. Interleukins in cancer: from biology to therapy
    2021 528 citations Peter Libby et al. profile →
  57. Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing
    1998 522 citations Peter Libby et al. profile →
  58. Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques
    1999 521 citations Galina K. Sukhova, Peter Libby et al. Circulation profile →
  59. Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
    2006 509 citations Peter Libby et al. Arteriosclerosis Thrombosis and Vascular Biology profile →
  60. Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
    2013 505 citations Peter Libby et al. profile →
  61. Interleukin-1 Beta as a Target for Atherosclerosis Therapy
    2017 486 citations Peter Libby profile →
  62. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
    2019 458 citations Jan H. Cornel, Tom Thurén et al. Circulation profile →
  63. Inflammatory Mechanisms: The Molecular Basis of Inflammation and Disease
    2007 440 citations Peter Libby profile →
  64. Ly-6C high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium
    2014 439 citations Peter Libby, Matthias Nahrendorf et al. profile →
  65. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
    2021 433 citations Paul M. Ridker, Peter Libby et al. profile →
  66. The Aging Cardiovascular System
    2017 429 citations Peter Libby, Thomas F. Lüscher et al. profile →
  67. IRF3 and type I interferons fuel a fatal response to myocardial infarction
    2017 412 citations Rainer H. Köhler, Peter Libby et al. profile →
  68. Inflammation, Immunity, and Infection in Atherothrombosis
    2018 401 citations Peter Libby, Paul M. Ridker et al. profile →
  69. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
    2018 395 citations Paul M. Ridker, Peter Libby et al. European Heart Journal profile →
  70. Reassessing the Mechanisms of Acute Coronary Syndromes
    2019 329 citations Peter Libby et al. profile →
  71. Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure
    2016 328 citations Ralph Weissleder, Peter Libby et al. profile →
  72. Acute Coronary Syndromes
    2017 327 citations Peter Libby et al. Circulation profile →
  73. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques
    2016 290 citations Peter Libby, Elena Aïkawa et al. profile →
  74. Inflammation during the life cycle of the atherosclerotic plaque
    2021 282 citations Peter Libby Cardiovascular Research profile →
  75. Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
    2020 274 citations Peter Libby et al. Arteriosclerosis Thrombosis and Vascular Biology profile →
  76. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
    2019 267 citations Alexander G. Bick, Peter Libby et al. Circulation profile →
  77. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases
    2020 262 citations Peter Libby et al. profile →
  78. Inflammation, Aging, and Cardiovascular Disease
    2022 261 citations Thomas F. Lüscher, Peter Libby et al. profile →
  79. Ferritinophagy and ferroptosis in the management of metabolic diseases
    2021 251 citations Peter Libby et al. profile →
  80. Neutrophil extracellular traps: from physiology to pathology
    2021 230 citations Peter Libby et al. Cardiovascular Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Libby United States 197 48.9k 39.4k 36.2k 35.7k 25.3k 768 148.1k
Paul M. Ridker United States 173 21.0k 0.4× 41.7k 1.1× 18.3k 0.5× 38.4k 1.1× 32.2k 1.3× 815 130.9k
Russell Ross United States 110 17.6k 0.4× 16.6k 0.4× 25.1k 0.7× 13.3k 0.4× 9.9k 0.4× 245 79.4k
Charles A. Dinarello United States 174 47.0k 1.0× 10.8k 0.3× 36.8k 1.0× 5.2k 0.1× 15.9k 0.6× 873 108.0k
Nader Rifai United States 122 9.1k 0.2× 21.1k 0.5× 9.2k 0.3× 21.5k 0.6× 21.7k 0.9× 455 77.6k
Yūji Matsuzawa Japan 123 8.3k 0.2× 14.8k 0.4× 16.7k 0.5× 16.7k 0.5× 36.8k 1.5× 700 80.5k
Michael Karin United States 229 60.2k 1.2× 13.4k 0.3× 113.1k 3.1× 4.3k 0.1× 23.0k 0.9× 652 212.6k
Valentı́n Fuster United States 149 8.4k 0.2× 34.0k 0.9× 9.7k 0.3× 53.8k 1.5× 11.1k 0.4× 1.3k 101.3k
Giuseppe Remuzzi Italy 144 17.9k 0.4× 12.4k 0.3× 16.0k 0.4× 17.9k 0.5× 5.7k 0.2× 1.3k 95.1k
Christian Weber Germany 131 22.5k 0.5× 9.8k 0.2× 22.5k 0.6× 8.0k 0.2× 7.5k 0.3× 1.1k 69.1k
Scott M. Grundy United States 145 5.2k 0.1× 51.2k 1.3× 19.0k 0.5× 39.8k 1.1× 31.8k 1.3× 603 160.2k

Countries citing papers authored by Peter Libby

Since Specialization
Citations

This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).

Fields of papers citing papers by Peter Libby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.

Co-authorship network of co-authors of Peter Libby

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Libby. A scholar is included among the top collaborators of Peter Libby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Libby. Peter Libby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heidecker, Bettina, Peter Libby, Vassilios S. Vassiliou, et al.. (2025). Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. European Heart Journal. 46(36). 3518–3531. 9 indexed citations
2.
Saba, Luca, Riccardo Cau, Rocco Vergallo, et al.. (2025). Carotid artery atherosclerosis: mechanisms of instability and clinical implications. European Heart Journal. 46(10). 904–921. 7 indexed citations
3.
Leistner, David M., Diaa Hakim, Youssef S. Abdelwahed, et al.. (2024). Endothelial Shear Stress Metrics Associate With Proinflammatory Pathways at the Culprit Site of Coronary Erosion. JACC Basic to Translational Science. 9(11). 1269–1283. 6 indexed citations
4.
Virmani, Renu, Kenji Kawai, Valentina Nardi, et al.. (2024). Coronary Artery Calcification: Current Concepts and Clinical Implications. Circulation. 149(3). 251–266. 68 indexed citations breakdown →
5.
Nakao, Tetsushi & Peter Libby. (2023). IL-6 helps weave the inflammatory web during acute coronary syndromes. Journal of Clinical Investigation. 133(11). 11 indexed citations
6.
Liu, Wenli, Mustafa Yalçınkaya, Malgorzata Olszewska, et al.. (2023). Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nature Cardiovascular Research. 2(6). 572–586. 38 indexed citations
7.
Kalaycı, Arzu, C. Michael Gibson, Paul M. Ridker, et al.. (2022). ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future. Current Atherosclerosis Reports. 24(7). 585–597. 22 indexed citations
8.
Guo, Junli, Yuanyuan Zhang, Tianxiao Liu, et al.. (2022). Allergic asthma is a risk factor for human cardiovascular diseases. Nature Cardiovascular Research. 1(5). 417–430. 17 indexed citations
9.
Zhang, Xian, Songyuan Luo, Minjie Wang, et al.. (2022). Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation. Nature Communications. 13(1). 7582–7582. 19 indexed citations
10.
Cornel, Jan H., Michael H. Davidson, Peter Libby, et al.. (2022). Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio. JAMA Cardiology. 8(2). 177–177. 27 indexed citations
11.
Tokgözoğlu, Lâle & Peter Libby. (2021). The dawn of a new era of targeted lipid-lowering therapies. European Heart Journal. 43(34). 3198–3208. 104 indexed citations
12.
Ketelhuth, Daniel F.J., Esther Lutgens, Magnus Bäck, et al.. (2019). Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology. Cardiovascular Research. 115(9). 1385–1392. 68 indexed citations
13.
Jaiswal, Siddhartha & Peter Libby. (2019). Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nature Reviews Cardiology. 17(3). 137–144. 235 indexed citations
14.
Shiomi, Masashi, Tatsuro Ishida, Tsutomu Kobayashi, et al.. (2013). Vasospasm of Atherosclerotic Coronary Arteries Precipitates Acute Ischemic Myocardial Damage in Myocardial Infarction–Prone Strain of the Watanabe Heritable Hyperlipidemic Rabbits. Arteriosclerosis Thrombosis and Vascular Biology. 33(11). 2518–2523. 33 indexed citations
15.
Ridker, Paul M., Campbell P. Howard, Verena Walter, et al.. (2012). Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen. Circulation. 126(23). 2739–2748. 430 indexed citations
16.
Świrski, Filip K., Matthias Nahrendorf, Martin Etzrodt, et al.. (2009). Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites. Science. 325(5940). 612–616. 1708 indexed citations breakdown →
17.
Chatzizisis, Yiannis S., Aaron B. Baker, Galina K. Sukhova, et al.. (2008). Abstract 1945: Low Endothelial Shear Stress (ESS)-Mediated Elastolytic Activity Promotes the Formation of High Risk Atherosclerotic Plaques in the Coronary Arteries. Circulation. 118. 1 indexed citations
18.
Ridker, Paul M., Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, et al.. (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. 359(21). 2195–2207. 4712 indexed citations breakdown →
19.
Nahrendorf, Matthias, Filip K. Świrski, Elena Aïkawa, et al.. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. The Journal of Experimental Medicine. 204(12). 3037–3047. 1769 indexed citations breakdown →
20.
Beckman, Joshua A., Mark A. Creager, & Peter Libby. (2002). Postprandial Hyperglycemia and Risk of Atherosclerosis—Reply. JAMA. 288(8). 955–955. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul M. Ridker Breakdown of academic impact, for papers by Russell Ross Breakdown of academic impact, for papers by Charles A. Dinarello Breakdown of academic impact, for papers by Nader Rifai Breakdown of academic impact, for papers by Yūji Matsuzawa Breakdown of academic impact, for papers by Michael Karin Breakdown of academic impact, for papers by Valentı́n Fuster Breakdown of academic impact, for papers by Giuseppe Remuzzi Breakdown of academic impact, for papers by Christian Weber Breakdown of academic impact, for papers by Scott M. Grundy
Rankless by CCL
2026